21 related news articles for Influenza

  • Flu season 2023 – all your questions answered

    Influenza expert, A/Prof Michelle Tate shares everything that you need to know for the 2023 flu season, including who is most at risk. …  Read more

    Associate Professor Michelle Tate discussing the Flu season 2023
  • Hudson News Winter 2023

    Director’s message: For children with cancer, change starts here. Childhood cancer is rare but devastating and new treatment options are desperately needed. In the last four decades the US Food and Drug Authority (FDA) has approved 500 drugs for adult cancers but just 12 to treat childhood cancers.…  Read more

    Professor Elizabeth Hartland
  • 2023 Victorian Medical Research Acceleration Fund success

    Hudson Institute research into treatments for severe influenza and pelvic organ prolapse have received funding in the Victorian Medical Research Acceleration grants 2023.…  Read more

    Associate Professor Michelle Tate and Dr Shayanti Mukherjee at Hudson Institute
  • New therapy gives important flu treatment option

    The discovery of a new class of host-targeted therapy could give the medical profession a much-needed treatment option for serious flu infections.…  Read more

    Dr Lauren Ely, Dr Chris Harpur, A/Prof Michelle Tate, Dr Alison West, Dr Andrew Gearing
  • Searching for clues to how RNA triggers the immune system

    A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.…  Read more

    Dr Natália Sampaio from the Regulation of Interferon and Innate Signalling Research Group
  • Victorian government funding boost for new anti-inflammatory treatments

    Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.…  Read more

    Associate Professor Michael Gantier's groundbreaking research into inflammation has attracted funding support from the Victorian government to assist with new anti-inflammatory treatments.
  • RNA boost for autoimmune disease

    The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

    Associate Professor Michael Gantier has been awarded a new grant to research further into RNA-based treatments for autoimmune diseases.
  • Flu season 2022 – what you need to know

    After two years of unusually low influenza infections due to social distancing, flu season 2022 is shaping up as a bad one for Australia. Influenza expert, Associate Professor Michelle Tate, answers some of the most frequently asked questions about flu and what we can expect in Australia this winter.…  Read more

    Associate Professor Michelle Tate from the Viral Immunity and Immunopathology Research Group at Hudson Institute
  • Targeting viral lung infections two ways

    A new anti-viral drug to target the cause of viral lung infections and the infection itself could be a game-changer in treating severe influenza.…  Read more

    Associate Professor Michelle Tate from the Viral Immunity and Immunopathology Research Group at Hudson Institute of Medical Research
  • Preparing for the next pandemic

    Leading virus scientist, Associate Professor Michelle Tate explains why new treatments are needed alongside vaccines.…  Read more

    Associate Professor Michelle Tate research in Inflammation
  • NHMRC Ideas Grant success

    Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

    Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

  • All in your genes: new tool investigates on and off switch for genes

    Our genetic material can predispose us to a number of diseases and conditions. Technologies to edit or change our genes are still in their infancy, so scientists are instead looking for ways to use treatments to stop genes that cause health conditions from being turned on.…  Read more

    Professor Paul Hertzog and Dr Jamie Gearing investigating gene pathways at Hudson Institute
  • Could flu deaths be relegated to history?

    A drug used in WW II to treat inflammation may hold the key to saving lives in the fight against flu deaths.…  Read more

  • Seven facts you need to know about the flu

    Influenza expert Dr Michelle Tate answers frequently asked questions about the flu and addresses misconceptions that often come up in conversation during the winter months.…  Read more

    Morphology of the swine flu virus.
  • Hudson Institute scientists awarded Young Tall Poppy Awards

    Two Hudson Institute scientists, Dr Michelle Tate and Dr Erin McGillick, have been presented with prestigious Victorian Young Tall Poppy Science Awards in recognition of their outstanding research achievements and community engagement.…  Read more

    Dr Michelle Tate and Dr Erin McGillick receives 2021 Young Tall Poppy Award
  • Fighting a deadly pandemic

    Why do seasonal strains of influenza make many people sick yet cause relatively few deaths, while 40 per cent of people affected by strains of avian influenza, or ‘bird flu’, succumb to their infection? A discovery by Associate Professor Ashley Mansell could form a strategy to protect the world’s population from a potential global outbreak…  Read more

  • Why has the 2017 flu season been so bad?

    There have been more than 2.5 times the number of laboratory confirmed cases of flu (160,000) in Australia compared with the same period last year. The effects of a bumper flu season are still being felt well into spring, with moderate levels of flu activity expected to linger into October. Around 800 people die from the…  Read more

    Influenza cell image
  • Emerging leader in influenza research promoted

    Emerging leader in viral pathogenesis and immunology, Dr Michelle Tate has received a promotion to lead her own research group within the Centre for Innate Immunity and Infectious Diseases. Dr Tate’s research group, ‘Viral immunity and immunopathology’ will focus on the understanding the induction of hyperinflammation during an influenza virus infection. “My research aims to…  Read more

    Dr Michelle Tate from the Viral Immunity and Immunopathology Research Group at Hudson Institute
  • NHMRC Fellowships awarded to Hudson Institute researchers

    Hudson Institute of Medical Research researchers have been awarded National Health and Medical Research Council Fellowships in the latest funding announcements.…  Read more

    Dr Michelle Tate from the Viral Immunity and Immunopathology Research Group at Hudson Institute
  • WWI antiseptic could be key to fighting 21st century viral infections

    Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.…  Read more

  • Hudson Institute discovery could help ‘buy time’ during global avian influenza pandemic

    A team of researchers at Hudson Institute of Medical Research have found that timely blocking of the body’s own immune response to infection from a severe or pathogenic strain of influenza could be vital in treating patients infected during a global pandemic.…  Read more